GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Suzuken Co Ltd (TSE:9987) » Definitions » EBIT

Suzuken Co (TSE:9987) EBIT : 円40,669 Mil (TTM As of Dec. 2023)


View and export this data going back to 1995. Start your Free Trial

What is Suzuken Co EBIT?

Suzuken Co's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2023 was 円14,031 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was 円40,669 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Suzuken Co's annualized ROC % for the quarter that ended in Dec. 2023 was 8.63%. Suzuken Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 44.37%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Suzuken Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 33.53%.


Suzuken Co EBIT Historical Data

The historical data trend for Suzuken Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Suzuken Co EBIT Chart

Suzuken Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 45,534.00 41,861.00 12,606.00 22,535.00 30,636.00

Suzuken Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10,504.00 3,585.00 5,091.00 17,962.00 14,031.00

Competitive Comparison of Suzuken Co's EBIT

For the Medical Distribution subindustry, Suzuken Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Suzuken Co's EV-to-EBIT Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Suzuken Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Suzuken Co's EV-to-EBIT falls into.



Suzuken Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円40,669 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Suzuken Co  (TSE:9987) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Suzuken Co's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

ROC % (Q: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2023 ) + Invested Capital (Q: Dec. 2023 ))/ count )
=39816 * ( 1 - 31.46% )/( (320482 + 311818)/ 2 )
=27289.8864/316150
=8.63 %

where

Note: The Operating Income data used here is four times the quarterly (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Suzuken Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2023  Q: Dec. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=56124/( ( (124556 + max(-96148, 0)) + (128452 + max(-80756, 0)) )/ 2 )
=56124/( ( 124556 + 128452 )/ 2 )
=56124/126504
=44.37 %

where Working Capital is:

Working Capital(Q: Sep. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(585517 + 153202 + 29914) - (815695 + 0 + 49086)
=-96148

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(586850 + 171453 + 30089) - (831155 + 0 + 37993)
=-80756

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Suzuken Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2023 )
=40669/121307.630
=33.53 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Suzuken Co EBIT Related Terms

Thank you for viewing the detailed overview of Suzuken Co's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Suzuken Co (TSE:9987) Business Description

Traded in Other Exchanges
N/A
Address
8 Higashi Kataha-machi, Higashi-ku, Nagoya, JPN, 461-8701
Suzuken Co Ltd is a Japanese drug manufacturer. It functions through four segments: Pharmaceutical Wholesale, which sells pharmaceuticals, diagnostic drugs, and medical equipment and materials; The Pharmaceutical Manufacturing, which produces pharmaceuticals and diagnostic drugs; The Insurance Pharmacy dispenses operations based on prescriptions from medical institutions and the Medical-related Service and Others segment which sells medical books, provides nursing services and manufactures physiological examination equipment.

Suzuken Co (TSE:9987) Headlines

No Headlines